Clinical Trials Arena December 5, 2024
Robert Barrie

Vasee Moorthy highlighted key areas of WHO’s new guidance for best practice in trials at the Outsourcing in Clinical Trials East Asia conference in Seoul.

Systematic reviews are needed to address gaps in population representation in clinical trials to ensure the quality level of evidence rises, according to a senior adviser at the World Health Organization (WHO).

Vasee Moorthy, senior adviser in WHO’s science division, was speaking at the Outsourcing in Clinical Trials and Clinical Trial Supply East Asia held in Seoul, South Korea, from 3 to 4 December.

“We often see that the populations that are most in need of interventions are not included in clinical trials,” Moorthy said.

Underrepresented populations are one of the key areas being addressed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
2024: record year for AI trials
Future Trends for Clinical Trials in 2025 and Beyond
The Future of Clinical Trials: Four Key Trends to Watch in 2025
Small cell lung cancer: Navigating the global clinical trial landscape
Generative AI has ‘potential to revolutionise clinical development’

Share This Article